Apparently sales were so abysmal for Pfizer’s insulin inhaler known as Exubera that the drug giant, manufacturer of bestselling pill Viagra, has killed it. Patients only spent a droopy $12 million on ...

NEW YORK (Reuters) - MannKind Corp said on Thursday it was suspending talks with potential partners for its experimental form of inhaled insulin due to negative market sentiment about such products, ...

NEW YORK, April 9 (Reuters) - Pfizer Inc and Nektar Therapeutics said on Wednesday clinical trials of the inhaled insulin Exubera found increased cases of lung cancer, leading Nektar to stop seeking a ...

Pfizer Inc. reported that its third-quarter earnings fell 77%, largely reflecting charges associated with the company's decision to stop selling Exubera, an insulin drug that is delivered via inhaler.